| High Frequency of Glucose Utilizing Mutants in Shewanella oneidensis MR-1. | |
| | |
MedLine Citation:
|
PMID: 22092702 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Shewanella oneidensis MR-1 has conventionally been considered unable to use glucose as a carbon substrate for growth. The genome sequence of S. oneidensis MR-1 however, suggests the ability to use glucose. Here we demonstrate that during initial glucose exposure, S. oneidensis MR-1 quickly and frequently gains the ability to utilize glucose as a sole carbon source, in contrast to wild-type S. oneidensis which cannot immediately use glucose as a sole carbon substrate. HPLC and (14) C-glucose tracer studies confirm the disappearance in cultures and assimilation and respiration, respectively, of glucose. The relatively short time frame with which S. oneidensis MR-1 gained the ability to use glucose raises interesting ecological implications. |
| | |
Authors:
|
Erinn C Howard; Leila J Hamdan; Stephen E Lizewski; Bradley R Ringeisen |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-11-5 |
Journal Detail:
|
Title: FEMS microbiology letters Volume: - ISSN: 1574-6968 ISO Abbreviation: - Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7705721 Medline TA: FEMS Microbiol Lett Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved. |
Affiliation:
|
National Research Council, Washington, D.C.; Bioenergy and Biofabrication Section, Code 6115. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Assimilatory nitrate utilization by bacteria on the West Florida Shelf as determined by stable isoto...
Next Document: Evidence for an exercise induced increase of TNF-? and IL-6 in marathon runners.